CA2387532A1 - Suppressor of anemia and appetite suppressor - Google Patents

Suppressor of anemia and appetite suppressor Download PDF

Info

Publication number
CA2387532A1
CA2387532A1 CA002387532A CA2387532A CA2387532A1 CA 2387532 A1 CA2387532 A1 CA 2387532A1 CA 002387532 A CA002387532 A CA 002387532A CA 2387532 A CA2387532 A CA 2387532A CA 2387532 A1 CA2387532 A1 CA 2387532A1
Authority
CA
Canada
Prior art keywords
suppressor
appetite
methionine
anemia
threonine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002387532A
Other languages
French (fr)
Other versions
CA2387532C (en
Inventor
Yasuko Kawamata
Takeshi Kimura
Makoto Miura
Sakino Toue
Ryousei Sakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2387532A1 publication Critical patent/CA2387532A1/en
Application granted granted Critical
Publication of CA2387532C publication Critical patent/CA2387532C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Abstract

The present invention provides a method for suppressing hemolytic anemia by selectively ameliorating reticulocyte increase and iron deposition on spleen as the side effects of methionine and particularly, an appetite suppressor with reduced such side effects, where threonine is used as the effective ingredient of the suppressor of hemolytic anemia due to methionine and a combination of methionine and threonine is used as the effective ingredient of the appetite suppressor.
CA002387532A 2001-05-31 2002-05-27 Suppressor of anemia and appetite suppressor Expired - Fee Related CA2387532C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001165242 2001-05-31
JP2001-165242 2001-05-31
JP2002150918A JP4300753B2 (en) 2001-05-31 2002-05-24 Anemia suppressor and appetite suppressant
JP2002-150918 2002-05-24

Publications (2)

Publication Number Publication Date
CA2387532A1 true CA2387532A1 (en) 2002-11-30
CA2387532C CA2387532C (en) 2009-04-14

Family

ID=26616132

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002387532A Expired - Fee Related CA2387532C (en) 2001-05-31 2002-05-27 Suppressor of anemia and appetite suppressor

Country Status (4)

Country Link
US (2) US20030018075A1 (en)
EP (1) EP1262178A3 (en)
JP (1) JP4300753B2 (en)
CA (1) CA2387532C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331366A1 (en) * 2003-07-11 2005-01-27 Degussa Ag Granulating feed additives containing amino acids and/or vitamins, especially L-threonine, optionally in fermentation broth form, using circulating fluidized bed
US9192593B2 (en) 2006-08-30 2015-11-24 Ajinomoto Co., Inc. Amino-acid containing composition for inhibiting accumulation of fat
JP5229678B2 (en) * 2006-08-30 2013-07-03 味の素株式会社 Amino acid-containing composition for inhibiting fat accumulation
US20110229601A1 (en) * 2008-10-06 2011-09-22 Wm. Wrigley Jr. Company Chewing gum containing low dose amounts of water soluble vitamins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4042688A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of providing high-protein nutrition by the oral administration of a predigested protein composition
JPS56110617A (en) * 1980-02-08 1981-09-01 Ajinomoto Co Inc Nutrient composition for young child
FR2628298A1 (en) * 1988-03-09 1989-09-15 Giacometti Serge Quinoa based dietary food prods. - is milk obtd. by dispersing Quinoa flour in water
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5273754A (en) * 1992-03-27 1993-12-28 Mann Morris A Appetite suppressant composition and method relating thereto
JPH0624977A (en) * 1992-07-10 1994-02-01 Rikagaku Kenkyusho Antiobestic agent and antilipidemic agent
JP4484254B2 (en) * 1995-12-06 2010-06-16 佐々木化学工業株式会社 Amino acid composition
CN1053653C (en) * 1997-08-29 2000-06-21 北京巨能亚太生命科学研究中心 Neo-L-threonic acid derivatives
US6103748A (en) * 1998-06-19 2000-08-15 Bryan; Thomas B. Method of treating an autoimmune disorder
US6468988B1 (en) * 1999-03-01 2002-10-22 Morris A. Mann Composition that regulates and diminishes appetite and methods relating thereto
JP2001165242A (en) 1999-12-08 2001-06-19 Toyo Tire & Rubber Co Ltd Vibration isolator and its stopper fitting
JP2002150918A (en) 2000-11-08 2002-05-24 Daito Communication Apparatus Co Ltd Protective element
US6420350B1 (en) * 2001-01-18 2002-07-16 Goen Group, Inc. Weight loss product

Also Published As

Publication number Publication date
US20030018075A1 (en) 2003-01-23
US20040214894A1 (en) 2004-10-28
JP2003048830A (en) 2003-02-21
CA2387532C (en) 2009-04-14
JP4300753B2 (en) 2009-07-22
EP1262178A2 (en) 2002-12-04
US7388030B2 (en) 2008-06-17
EP1262178A3 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
WO2005033353A3 (en) Alloy in particular for a bearing coating
CA2417590A1 (en) Prophylactic or ameliorative agent for insulin resistance and/or obesity
WO2003076530A3 (en) Coatings having low volatile organic compound content
WO2003048148A3 (en) Statin-like compounds
WO2001094480A3 (en) Reduction of surface tension
TW371638B (en) Actuating tool
MXPA03006774A (en) Coating compositions for modifying surfaces.
CA2381678A1 (en) Friction control composition with enhanced retentivity
EP1499308A4 (en) Tri-substituted heteroaryls and methods of making and using the same
TW200724033A (en) Anthranilamide arthropodicide treatment
AU2002235928A1 (en) Method for coating metallic surfaces and use of the substrates coated in this manner
PL369603A1 (en) Coating method and coating
WO2004028482A3 (en) Packaged personal care compositions
CA2000762A1 (en) Lubricant compositions
CA2142410A1 (en) Nitro-substituted polymeric corrosion inhibition for aluminum flake pigment
CA2387532A1 (en) Suppressor of anemia and appetite suppressor
EP1344515A4 (en) Skin cosmetics
AU2002322029A1 (en) Inoculants for intermetallic layer
EP1398306A3 (en) A (1'R, 2'S, 5'R)-3-l-Menthoxyalkan-1-ol cooling sensate
CA2352392A1 (en) Eletriptan hydrobromide monohydrate
CA2341748A1 (en) Stabilized alkyd based compositions containing haloproprynyl compounds
WO2007001383A8 (en) Superconductor components
WO1999037291A3 (en) Utilization of substituted sulfonamides as antiviral agents and novel substances
AU2001294494A1 (en) Structure that counteracts bio-fouling in aquatic environments
AU2003237241A1 (en) Composition, kit and method for cleaning and/or treating surfaces

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130528